XML 37 R23.htm IDEA: XBRL DOCUMENT v3.24.3
LOSS PER SHARE
 9 Months Ended
Sep. 30, 2024
Earnings Per Share [Abstract]  
LOSS PER SHARE LOSS PER SHARE
Loss per share attributable to Bausch Health Companies Inc. is calculated as follows:
Three Months Ended September 30,Nine Months Ended September 30,
(in millions, except per share amounts)2024202320242023
Net loss attributable to Bausch Health Companies Inc.$(85)$(378)$(139)$(553)
Basic and diluted weighted-average common shares outstanding368.4 365.4 367.7 364.5 
Basic and diluted loss per share attributable to Bausch Health Companies Inc.$(0.23)$(1.03)$(0.38)$(1.52)
During the three and nine months ended September 30, 2024 and 2023, all potential common shares issuable for stock options and RSUs were excluded from the calculation of diluted loss per share, as the effect of including them would have been anti-dilutive. The dilutive effect of potential common shares issuable for stock options and RSUs on the weighted-average number of common shares outstanding would have been approximately 2,245,000 and 2,656,000 common shares for the three and nine months ended September 30, 2024, respectively, and approximately 3,075,000 and 2,931,000 common shares for the three and nine months ended September 30, 2023, respectively.
During the three and nine months ended September 30, 2024, time-based RSUs, performance-based RSUs and stock options to purchase approximately 14,554,000 and 14,416,000 common shares, respectively, were not included in the computation of diluted earnings per share because the effect would have been anti-dilutive under the treasury stock method.
During the three and nine months ended September 30, 2023, time-based RSUs, performance-based RSUs and stock options to purchase approximately 12,268,000 and 12,387,000 common shares, respectively, were not included in the computation of diluted earnings per share because the effect would have been anti-dilutive under the treasury stock method.
During each of the three and nine months ended September 30, 2023, 637,000 performance-based RSUs were not included in the computation of diluted earnings per share as the required performance conditions had not been met.